FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Tagg

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Philip Wescombe; John D F Hale; Nicholas C K Heng; John Tagg
Developing oral probiotics from Streptococcus salivarius.
Philip Wescombe; Anna L Wescombe; Jeremy P Burton; Karen P Dierksen; Kristin H Dyet; Megan A Inglis; Ralph W Jack; Daniel A Power; John Tagg
Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.
Jeremy P Burton; Peter A Cadieux; Philip Wescombe; John Tagg
Beneficial microbes for the oral cavity: time to harness the oral streptococci?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Tagg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Philip Wescombe; John D F Hale; Nicholas C K Heng; John Tagg
Developing oral probiotics from Streptococcus salivarius.
Future microbiology 2012;7(12):1355-71.
2012: Philip Wescombe; Anna L Wescombe; Jeremy P Burton; Karen P Dierksen; Kristin H Dyet; Megan A Inglis; Ralph W Jack; Daniel A Power; John Tagg
Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.
International journal of microbiology 2012;2012():738503.
2011: Jeremy P Burton; Peter A Cadieux; Philip Wescombe; John Tagg
Beneficial microbes for the oral cavity: time to harness the oral streptococci?
Beneficial microbes 2011;2(2):93-101.
2010: Pearl M Swe; Nicholas C K Heng; Gregory M Cook; John Tagg; Ralph W Jack
Identification of DysI, the immunity factor of the streptococcal bacteriocin dysgalacticin.
Applied and environmental microbiology 2010;76(23):7885-9.
2009: Philip Wescombe; Nicholas C K Heng; Jeremy P Burton; Chris N Chilcott; John Tagg
Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.
Future microbiology 2009;4(7):819-35.
2009: Pearl M Swe; Gregory M Cook; John Tagg; Ralph W Jack
Mode of action of dysgalacticin: a large heat-labile bacteriocin.
The Journal of antimicrobial chemotherapy 2009;63(4):679-86.
2008: D A Power; Jeremy P Burton; Chris N Chilcott; P J D Dawes; John Tagg
Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(12):1261-3.
2008: Celine Cosseau; Deirdre A Devine; Edie Dullaghan; Jennifer L Gardy; Avinash Chikatamarla; Shaan Gellatly; Lorraine L Yu; Jelena Pistolic; Reza Falsafi; John Tagg; Robert E W Hancock
The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis.
Infection and immunity 2008;76(9):4163-75.
2008: Rhys J Jones; Hassan M Hussein; Monique Zagorec; Gale Brightwell; John Tagg
Isolation of lactic acid bacteria with inhibitory activity against pathogens and spoilage organisms associated with fresh meat.
Food microbiology 2008;25(2):228-34.
2007: Nicholas C K Heng; Grace A Burtenshaw; Ralph W Jack; John Tagg
Ubericin A, a class IIa bacteriocin produced by Streptococcus uberis.
Applied and environmental microbiology 2007;73(23):7763-6.
2007: Pearl M Swe; Nicholas C K Heng; Yi-Tian Ting; Hayley J Baird; Alan Carne; Andreas Tauch; John Tagg; Ralph W Jack
ef1097 and ypkK encode enterococcin V583 and corynicin JK, members of a new family of antimicrobial proteins (bacteriocins) with modular structure from Gram-positive bacteria.
Microbiology (Reading, England) 2007;153(Pt 10):3218-27.
2007: Cynthia L Robson; Philip Wescombe; Nikolai A Klesse; John Tagg
Isolation and partial characterization of the Streptococcus mutans type AII lantibiotic mutacin K8.
Microbiology (Reading, England) 2007;153(Pt 5):1631-41.
2007: Ruth E Wirawan; Kara M Swanson; Torsten Kleffmann; Ralph W Jack; John Tagg
Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis.
Microbiology (Reading, England) 2007;153(Pt 5):1619-30.
2007: Karen P Dierksen; Chris J Moore; Megan A Inglis; Philip Wescombe; John Tagg
The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.
FEMS microbiology ecology 2007;59(3):584-91.
2007: Otto Hyink; Philip Wescombe; Mathew Upton; Nancy L Ragland; Jeremy P Burton; John Tagg
Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.
Applied and environmental microbiology 2007;73(4):1107-13.
2007: Nicholas C K Heng; John Tagg; Geoffrey R Tompkins
Competence-dependent bacteriocin production by Streptococcus gordonii DL1 (Challis).
Journal of bacteriology 2007;189(4):1468-72.
2007: Ellen De Backer; Rita Verhelst; Hans Verstraelen; Mohammed A Alqumber; Jeremy P Burton; John Tagg; Marleen Temmerman; Mario Vaneechoutte
Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners.
BMC microbiology 2007;7():115.
2007: Eileen B O'Connor; Paul D Cotter; Paula O'Connor; Orla O'Sullivan; John Tagg; R Paul Ross; Colin Hill
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.
BMC microbiology 2007;7():24.
2006: M Al-Qumber; John Tagg
Commensal bacilli inhibitory to mastitis pathogens isolated from the udder microbiota of healthy cows.
Journal of applied microbiology 2006;101(5):1152-60.
2006: Philip Wescombe; Jeremy P Burton; Peter A Cadieux; Nikolai A Klesse; Otto Hyink; Nicholas C K Heng; Chris N Chilcott; Gregor Reid; John Tagg
Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Antonie van Leeuwenhoek 2006;90(3):269-80.
2006: Nicholas C K Heng; Nancy L Ragland; Pearl M Swe; Hayley J Baird; Megan A Inglis; John Tagg; Ralph W Jack
Dysgalacticin: a novel, plasmid-encoded antimicrobial protein (bacteriocin) produced by Streptococcus dysgalactiae subsp. equisimilis.
Microbiology (Reading, England) 2006;152(Pt 7):1991-2001.
2006: Nicholas C K Heng; John Tagg; Geoffrey R Tompkins
Identification and characterization of the loci encoding the competence-associated alternative sigma factor of Streptococcus gordonii.
FEMS microbiology letters 2006;259(1):27-34.
2006: Jeremy P Burton; Philip Wescombe; Chris J Moore; Chris N Chilcott; John Tagg
Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.
Applied and environmental microbiology 2006;72(4):3050-3.
2006: Jeremy P Burton; Chris N Chilcott; Chris J Moore; G Speiser; John Tagg
A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Journal of applied microbiology 2006;100(4):754-64.
2006: Philip Wescombe; Mathew Upton; Karen P Dierksen; Nancy L Ragland; Senthuran Sivabalan; Ruth E Wirawan; Megan A Inglis; Chris J Moore; Glenn V Walker; Chris N Chilcott; Howard F Jenkinson; John Tagg
Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
Applied and environmental microbiology 2006;72(2):1459-66.
2006: Ruth E Wirawan; Nikolai A Klesse; Ralph W Jack; John Tagg
Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis.
Applied and environmental microbiology 2006;72(2):1148-56.
2005: Otto Hyink; Mayooran Balakrishnan; John Tagg
Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin.
FEMS microbiology letters 2005;252(2):235-41.
2005: Daniel A Power; Jeremy P Burton; Chris N Chilcott; John Tagg; P J D Dawes
Non-culture-based analysis of bacterial populations from patients with chronic rhinosinusitis.
Journal of clinical microbiology 2005;43(11):5822-4.
2005: John D F Hale; Yi-Tian Ting; Ralph W Jack; John Tagg; Nicholas C K Heng
Bacteriocin (mutacin) production by Streptococcus mutans genome sequence reference strain UA159: elucidation of the antimicrobial repertoire by genetic dissection.
Applied and environmental microbiology 2005;71(11):7613-7.
2005: Jeremy P Burton; Chris N Chilcott; Mohammed Al-Qumber; Heather J L Brooks; Don Wilson; John Tagg; Celia Devenish
A preliminary survey of Atopobium vaginae in women attending the Dunedin gynaecology out-patients clinic: is the contribution of the hard-to-culture microbiota overlooked in gynaecological disorders?
The Australian & New Zealand journal of obstetrics & gynaecology 2005;45(5):450-2.
2005: John D F Hale; Nicholas C K Heng; Ralph W Jack; John Tagg
Identification of nlmTE, the locus encoding the ABC transport system required for export of nonlantibiotic mutacins in Streptococcus mutans.
Journal of bacteriology 2005;187(14):5036-9.
2005: Jeremy P Burton; Chris N Chilcott; John Tagg
The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics.
Oral diseases 2005;11 Suppl 1():29-31.
2004: Nicholas C K Heng; Grace A Burtenshaw; Ralph W Jack; John Tagg
Sequence analysis of pDN571, a plasmid encoding novel bacteriocin production in M-type 57 Streptococcus pyogenes.
Plasmid 2004;52(3):225-9.
2004: John D F Hale; Balakrishnan Balakrishnan; John Tagg
Genetic basis for mutacin N and of its relationship to mutacin I.
The Indian journal of medical research 2004;119 Suppl():247-51.
2004: John Tagg
Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
The Indian journal of medical research 2004;119 Suppl():13-6.
2003: Tony Walls; Dan Power; John Tagg
Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?
Journal of medical microbiology 2003;52(Pt 9):829-33.
2003: Philip Wescombe; John Tagg
Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.
Applied and environmental microbiology 2003;69(5):2737-47.
2003: John Tagg; Karen P Dierksen
Bacterial replacement therapy: adapting 'germ warfare' to infection prevention.
Trends in biotechnology 2003;21(5):217-23.
2002: Mayooran Balakrishnan; Robin S Simmonds; M Kilian; John Tagg
Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages.
Journal of medical microbiology 2002;51(11):941-8.
2001: M Upton; John Tagg; Philip Wescombe; Howard F Jenkinson
Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.
Journal of bacteriology 2001;183(13):3931-8.
2001: Mayooran Balakrishnan; Robin S Simmonds; John Tagg
Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci.
Caries research 2001;35(1):75-80.
2000: Mayooran Balakrishnan; Robin S Simmonds; John Tagg
Dental caries is a preventable infectious disease.
Australian dental journal 2000;45(4):235-45.
2000: Karen P Dierksen; Megan A Inglis; John Tagg
High pharyngeal carriage rates of Streptococcus pyogenes in Dunedin school children with a low incidence of rheumatic fever.
The New Zealand medical journal 2000;113(1122):496-9.
2000: Karen P Dierksen; John Tagg
Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis.
Journal of medical microbiology 2000;49(9):811-6.
2000: Karen P Dierksen; Nancy L Ragland; John Tagg
A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius.
Journal of clinical microbiology 2000;38(2):643-50.
2000: Mayooran Balakrishnan; Robin S Simmonds; Alan Carne; John Tagg
Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin.
FEMS microbiology letters 2000;183(1):165-9.
1999: M A Navaratna; H G Sahl; John Tagg
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene.
Infection and immunity 1999;67(8):4268-71.
1998: M A Navaratna; H G Sahl; John Tagg
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55.
Applied and environmental microbiology 1998;64(12):4803-8.
1997: Michael Chikindas; J Novák; P W Caufield; K Schilling; John Tagg
Microbially-produced peptides having potential application to the prevention of dental caries.
International journal of antimicrobial agents 1997;9(2):95-105.
1997: Robin S Simmonds; W J Simpson; John Tagg
Cloning and sequence analysis of zooA, a Streptococcus zooepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin.
Gene 1997;189(2):255-61.
1997: Geoffrey R Tompkins; M A Peavey; KR Birchmeier; John Tagg
Bacteriocin production and sensitivity among coaggregating and noncoaggregating oral streptococci.
Oral microbiology and immunology 1997;12(2):98-105.
1996: Robin S Simmonds; Lachlan Pearson; R C Kennedy; John Tagg
Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881.
Applied and environmental microbiology 1996;62(12):4536-41.
1996: Ingolf F Nes; John Tagg
Novel lantibiotics and their pre-peptides.
Antonie van Leeuwenhoek 1996;69(2):89-97.
1995: R W Jack; John Tagg; B Ray
Bacteriocins of gram-positive bacteria.
Microbiological reviews 1995;59(2):171-200.
1995: W J Simpson; N L Ragland; Clive W Ronson; John Tagg
A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes.
Developments in biological standardization 1995;85():639-43.
1994: R W Jack; A Carne; J Metzger; S Stefanović; Hans-Georg Sahl; G Jung; John Tagg
Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22.
European journal of biochemistry / FEBS 1994;220(2):455-62.
1994: R Jack; R Benz; John Tagg; Hans-Georg Sahl
The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22.
European journal of biochemistry / FEBS 1994;219(1-2):699-705.
1993: K F Ross; Clive W Ronson; John Tagg
Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3.
Applied and environmental microbiology 1993;59(7):2014-21.
1993: W L Hynes; Joseph J Ferretti; John Tagg
Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence.
Applied and environmental microbiology 1993;59(6):1969-71.
1992: J C Scott; Hans-Georg Sahl; A Carne; John Tagg
Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate.
FEMS microbiology letters 1992;72(1):97-102.
1992: R W Jack; John Tagg
Factors affecting production of the group A streptococcus bacteriocin SA-FF22.
Journal of medical microbiology 1992;36(2):132-8.
1991: Bhushan M Jayarao; Stephen P Oliver; John Tagg; K R Matthews
Genotypic and phenotypic analysis of Streptococcus uberis isolated from bovine mammary secretions.
Epidemiology and infection 1991;107(3):543-55.
1991: John Tagg; N L Ragland
Applications of BLIS typing to studies of the survival on surfaces of salivary streptococci and staphylococci.
The Journal of applied bacteriology 1991;71(4):339-42.
1991: S M James; John Tagg
The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci.
The New Zealand dental journal 1991;87(389):80-3.
1991: John Tagg; I van de Rijn
Inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes bacteriocinlike inhibitory substance.
Journal of clinical microbiology 1991;29(4):848-9.
1991: John Tagg
Studies of "BLIS-ful" oral bacteria.
The New Zealand dental journal 1991;87(387):14-6.
1990: N Ragland; John Tagg
Applications of bacteriocin-like inhibitory substance (BLIS) typing in a longitudinal study of the oral carriage of beta-haemolytic streptococci by a group of Dunedin schoolchildren.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1990;274(1):100-8.
1990: John Tagg; N L Ragland; Nigel Dickson
A longitudinal study of Lancefield group A streptococcus acquisitions by a group of young Dunedin schoolchildren.
The New Zealand medical journal 1990;103(897):429-31.
1989: K W Frisken; A J Laws; John Tagg; M B Orr
Environmental influences on the progression of clinical and microbiological parameters of sheep periodontal disease.
Research in veterinary science 1989;46(2):147-52.
1989: John Tagg; N Ragland; Nigel Dickson
High isolation rates of group A streptococci in pharyngeal cultures from a group of Dunedin schoolchildren: what does this signify?
The New Zealand medical journal 1989;102(862):85-6.
1988: Bryce M Buddle; John Tagg; M J Ralston
Use of an inhibitor typing scheme to study the epidemiology of Streptococcus uberis mastitis.
New Zealand veterinary journal 1988;36(3):115-9.
1988: K W Frisken; John Tagg; A J Laws; M B Orr
Suspected periodontopathic bacteria associated with broken-mouth periodontitis in sheep.
Journal of periodontal research 1988;23(1):18-21.
1987: Geoffrey R Tompkins; John Tagg
Bacteriocin-like inhibitory activity associated with beta-hemolytic strains of Streptococcus salivarius.
Journal of dental research 1987;66(8):1321-5.
1987: K W Frisken; John Tagg; A J Laws; M B Orr
Suspected periodontopathic microorganisms and their oral habitats in young children.
Oral microbiology and immunology 1987;2(2):60-4.
1987: Michael R D Barnham; G Cole; A Efstratiou; John Tagg; S A Skjold
Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections.
Epidemiology and infection 1987;98(2):171-82.
1987: M G Heap; John Tagg
Toxic shock syndrome.
The New Zealand medical journal 1987;100(820):169-71.
1987: M Crooks; S M James; John Tagg
Relationship of bacteriocin-like inhibitor production to the pigmentation and hemolytic activity of mutans streptococci.
Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1987;263(4):541-7.
1987: K W Frisken; John Tagg; A J Laws; M B Orr
Black-pigmented Bacteroides associated with broken-mouth periodontitis in sheep.
Journal of periodontal research 1987;22(2):156-9.
1987: B Tippet; K W Frisken; John Tagg
Quantification of the bacterium Bacteroides gingivalis in human dental plaque by detection of the trypsin-like protease activity of colonies imprinted on membrane filters.
Archives of oral biology 1987;32(2):151-2.
1986: W L Hynes; John Tagg
Proteinase-related broad-spectrum inhibitory activity among group-A streptococci.
Journal of medical microbiology 1986;22(3):257-64.
1986: John Tagg; L G Vugler
An inhibitor typing scheme for Streptococcus uberis.
The Journal of dairy research 1986;53(3):451-6.
1986: M Heap; John Tagg
Toxic shock syndrome--associated staphylococci: are New Zealand strains different?
The New Zealand medical journal 1986;99(803):427.
1986: W L Hynes; John Tagg
Role of proteinase in the formation of inhibitory levels of hematin by group A streptococcus cultures on blood-containing media.
Journal of clinical microbiology 1986;23(5):929-33.
1986: Geoffrey R Tompkins; John Tagg
Incidence and characterization of anti-microbial effects produced by Actinomyces viscosus and Actinomyces naeslundii.
Journal of dental research 1986;65(2):109-12.
1985: John Tagg
An inhibitor typing scheme applicable to Lancefield group E streptococci.
Canadian journal of microbiology 1985;31(11):1056-7.
1985: W L Hynes; John Tagg
Production of broad-spectrum bacteriocin-like activity by group A streptococci of particular M-types.
Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1985;259(2):155-64.
1984: John Tagg; S A Skjold
A bacteriocin produced by certain M-type 49 Streptococcus pyogenes strains when incubated anaerobically.
The Journal of hygiene 1984;93(2):339-44.
1984: John Tagg
Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types.
Journal of clinical microbiology 1984;19(6):884-7.
1984: John Tagg; D R Martin
Evaluation of a typing scheme for group A streptococci based upon bacteriocin-like inhibitor production.
Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1984;257(1):60-7.
1983: John Tagg; G Peters; E D Gray; L W Wannamaker
Bacterial interference and toxic shock syndrome.
Annals of internal medicine 1983;99(6):879-80.
1983: John Tagg; H K Wong
Inhibitor production by group-G streptococci of human and of animal origin.
Journal of medical microbiology 1983;16(4):409-15.
1983: W J Simpson; John Tagg
M-type 57 group A streptococcus bacteriocin.
Canadian journal of microbiology 1983;29(10):1445-51.
1983: C R Schofield; John Tagg
Bacteriocin-like activity of group B and group C streptococci of human and of animal origin.
The Journal of hygiene 1983;90(1):7-18.
1983: John Tagg; V Pybus; L V Phillips; T M Fiddes
Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius.
Archives of oral biology 1983;28(10):911-5.
1982: R P Dempster; John Tagg
The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.
Archives of oral biology 1982;27(2):151-7.
1981: John Tagg; C Russell
Bacteriocin production by Streptococcus salivarius strain P.
Canadian journal of microbiology 1981;27(9):918-23.
1981: C Russell; John Tagg
Role of bacteriocin during plaque formation by Streptococcus salivarius and Streptococcus sanguis on a tooth in an artificial mouth.
The Journal of applied bacteriology 1981;50(2):305-13.
1979: D W Johnson; John Tagg; L W Wannamaker
Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4.
Journal of medical microbiology 1979;12(4):413-27.
1979: John Tagg; L V Bannister
"Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors.
Journal of medical microbiology 1979;12(4):397-411.
1978: John Tagg; L W Wannamaker
Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus.
Antimicrobial agents and chemotherapy 1978;14(1):31-9.
1978: W Hryniewicz; E D Gray; John Tagg; L W Wannamaker; K Kanclerski; N Laible
Streptolysin S: purification and properties.
Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 1978;242(3):327-38.
1977: W Hryniewicz; John Tagg
[Biological properties of streptolysin S. I. Cytotoxic effect on cultured cells].
Medycyna doświadczalna i mikrobiologia 1977;29(3):173-8.
1976: W Hryniewicz; John Tagg
Bacteriocin production by group a streptococcal L-forms.
Antimicrobial agents and chemotherapy 1976;10(6):912-4.
1976: John Tagg; AS Dajani; L W Wannamaker
Bacteriocins of gram-positive bacteria.
Bacteriological reviews 1976;40(3):722-56.
1976: John Tagg; L W Wannamaker
Genetic basis of streptococcin A-FF22 production.
Antimicrobial agents and chemotherapy 1976;10(2):299-306.
1976: John Tagg; S Skjold; L W Wannamaker
Transduction of bacteriocin determinants in group A streptococci.
The Journal of experimental medicine 1976;143(6):1540-4.
1975: John Tagg; AS Dajani; L W Wannamaker
Bacteriocin of a group B streptococcus: partial purification and characterization.
Antimicrobial agents and chemotherapy 1975;7(6):764-72.
1973: John Tagg; AS Dajani; L W Wannamaker; E D Gray
Group A streptococcal bacteriocin. Production, purification, and mode of action.
The Journal of experimental medicine 1973;138(5):1168-83.
1973: John Tagg; E A Pihl; A R McGiven
Morphological changes in a susceptible strain of Streptococcus pyogenes treated with streptocin A.
Journal of general microbiology 1973;79(1):167-9.
1973: John Tagg; R Mushin
Pyocin-sensitivity testing as a means of typing Pseudomonas aeruginosa.
Journal of medical microbiology 1973;6(4):559-63.
1973: John Tagg; R S Read; A R McGiven
Bacteriocin of a group A streptococcus: partial purification and properties.
Antimicrobial agents and chemotherapy 1973;4(3):214-21.
1973: John Tagg; A R McGiven
Myoid cell antibody in rheumatic fever.
Immunological communications 1973;2(2):227-30.
1972: John Tagg; A R McGiven
Some possible autoimmune mechanisms in rheumatic carditis.
Lancet 1972;2(7779):686-8.
1972: John Tagg; A R McGiven; D A Guthrie
Heart-reactive antibodies in rheumatic fever.
The Medical journal of Australia 1972;1(13):621-4.
1971: G Ziv; R Mushin; John Tagg
Pyocine typing as an epidemiological marker in Pseudomonas aeruginosa mastitis in cattle.
The Journal of hygiene 1971;69(2):171-7.
1971: John Tagg; A R McGiven
Assay system for bacteriocins.
Applied microbiology 1971;21(5):943.
1971: M A Deighton; John Tagg; R Mushin
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 2. "Fingerprinting" of Ps. aeruginosa strains in a study of cross-infection in a children's hospital.
The Medical journal of Australia 1971;1(17):892-6.
1971: John Tagg; R Mushin
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 1. Pyocine typing of Ps. aeruginosa.
The Medical journal of Australia 1971;1(16):847-52.